These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347 [TBL] [Abstract][Full Text] [Related]
4. Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer. Dahlgren L; Erlandsson F; Lindquist D; Silfverswärd C; Hellström AC; Dalianis T Anticancer Res; 2006; 26(2A):829-32. PubMed ID: 16619476 [TBL] [Abstract][Full Text] [Related]
5. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy. Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068 [TBL] [Abstract][Full Text] [Related]
6. [Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix]. Hernádi Z; Sápy T; Kónya J; Veress G; Czeglédy J Orv Hetil; 1997 May; 138(20):1249-53. PubMed ID: 9244858 [TBL] [Abstract][Full Text] [Related]
7. Can recurrence of cervical cancer be predicted by human papillomavirus DNA in nodes or plasma? Peedicayil A; Sathish N; Gnanamony M; John S; Viswanathan FR; Naseema PS; Abraham P J Low Genit Tract Dis; 2009 Apr; 13(2):102-6. PubMed ID: 19387130 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma. Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554 [TBL] [Abstract][Full Text] [Related]
9. HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy. Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM Gynecol Oncol; 2011 Jun; 121(3):546-50. PubMed ID: 21334052 [TBL] [Abstract][Full Text] [Related]
10. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372 [TBL] [Abstract][Full Text] [Related]
11. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study. van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245 [TBL] [Abstract][Full Text] [Related]
15. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction]. Zheng Y; Peng ZL; Lou JY; Wang H Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients--a prospective study. Lukaszuk K; Liss J; Gulczynski J; Nowaczyk M; Nakonieczny M; Piatkowski M; Sliwinski W; Baay M; Wozniak I; Maj B; Lukaszuk M Gynecol Oncol; 2007 Mar; 104(3):721-6. PubMed ID: 17156830 [TBL] [Abstract][Full Text] [Related]
17. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma. Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival. Shah W; Hongwei C; Jin Z; Lifang D; Jun Y; Yili W Clin Oncol (R Coll Radiol); 2009 Dec; 21(10):768-74. PubMed ID: 19875274 [TBL] [Abstract][Full Text] [Related]
19. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up. Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065 [TBL] [Abstract][Full Text] [Related]
20. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells. Vermeulen CF; Jordanova ES; Szuhai K; Kolkman-Uljee S; Vrede MA; Peters AA; Schuuring E; Fleuren GJ Cancer Genet Cytogenet; 2007 Jun; 175(2):132-7. PubMed ID: 17556069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]